.. Algorithme-de-sélection-des-cas, 20 1.2. Cas probables et certains, p.37

H. Bocquet, M. Bagot, and J. Roujeau, Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS), Seminars in Cutaneous Medicine and Surgery, vol.15, issue.4, pp.250-257, 1996.
DOI : 10.1016/S1085-5629(96)80038-1

S. Tas and T. Simonart, Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome): An Update, Dermatology, vol.206, issue.4, pp.353-359, 2003.
DOI : 10.1159/000069956

M. Ben-m-'rad, S. Leclerc-mercier, P. Blanche, N. Franck, F. Rozenberg et al., Drug-Induced Hypersensitivity Syndrome, Medicine, vol.88, issue.3, pp.131-171, 2009.
DOI : 10.1097/MD.0b013e3181a4d1a1

Y. Kano, M. Tohyama, M. Aihara, S. Matsukura, H. Watanabe et al., Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms, Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)

S. Collot, N. Houhou, S. Ranger-rogez, V. Descamps, E. Mahé et al., Active Human Herpesvirus 6 Infection in a Patient with Drug Rash with Eosinophilia and Systemic Symptoms, Journal of Investigative Dermatology, vol.121, issue.1, pp.215-221, 2003.
DOI : 10.1046/j.1523-1747.2003.12333.x

S. Hung, W. Chung, L. Liou, C. Chu, M. Lin et al., HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol, Proceedings of the National Academy of Sciences, vol.102, issue.11, pp.4134-4143, 2005.
DOI : 10.1073/pnas.0409500102

S. Mallal, D. Nolan, C. Witt, G. Masel, A. Martin et al., Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir, The Lancet, vol.359, issue.9308, pp.727-759, 2002.
DOI : 10.1016/S0140-6736(02)07873-X

V. Descamps, B. Saïd, B. Sassolas, B. Truchetet, F. Avenel-audran et al., Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS) Ann Dermatol Vénéréologie, pp.703-711, 2010.
DOI : 10.1016/j.annder.2010.04.024

P. Cacoub, P. Musette, V. Descamps, O. Meyer, C. Speirs et al., The DRESS Syndrome: A Literature Review, The American Journal of Medicine, vol.124, issue.7, pp.588-97, 2011.
DOI : 10.1016/j.amjmed.2011.01.017

S. Kardaun, A. Sidoroff, L. Valeyrie-allanore, S. Halevy, B. Davidovici et al., Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, British Journal of Dermatology, vol.156, issue.3, pp.609-620, 2007.
DOI : 10.1111/j.1365-2133.2006.07332.x

T. Shiohara, M. Iijima, Z. Ikezawa, and K. Hashimoto, The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations, British Journal of Dermatology, vol.156, issue.5, pp.1083-1087, 2007.
DOI : 10.1016/j.jaad.2005.03.057

C. Holland, C. Malasky, A. Ogunkoya, and L. Bielory, Rapid Oral Desensitization to Isoniazid and Rifampin, Chest, vol.98, issue.6, pp.1518-1527, 1990.
DOI : 10.1378/chest.98.6.1518

K. Shebe, M. Ngwanya, N. Gantsho, and R. Lehloenya, Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man, Contact Dermatitis, vol.136, issue.2, pp.125-132, 2014.
DOI : 10.1111/cod.12155

F. Santiago, M. Gonçalo, R. Vieira, S. Coelho, and A. Figueiredo, Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS) Contact Dermatitis, 2010.
DOI : 10.1111/j.1600-0536.2009.01659.x

URL : http://hdl.handle.net/10400.4/724

. Afssaps, Bonnes pratiques de pharmacovigilance, 2011.

J. Lee, Y. Seol, D. Shin, D. Kim, H. Chun et al., A Case of the Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Following Isoniazid Treatment, Tuberculosis and Respiratory Diseases, vol.78, issue.1, p.27, 2015.
DOI : 10.4046/trd.2015.78.1.27

R. Rodríguez, V. Jover, I. Orozco, and J. Domenech, DRESS syndrome in a 19-year- old patient following the administration of first-line antituberculosis drugs, J Investig Allergol Clin Immunol, vol.22, issue.5, pp.380-381, 2012.

S. Lee, N. Yoon, S. Park, S. Lee, S. Um et al., Antituberculosis drug-induced drug rash with eosinophilia and systemic symptoms syndrome confirmed by patch testing, J Investig Allergol Clin Immunol, vol.20, issue.7, pp.631-633, 2010.

K. Ogawa, H. Morito, N. Kobayashi, T. Fukumoto, and H. Asada, Case of drug-induced hypersensitivity syndrome involving multiple-drug hypersensitivity, The Journal of Dermatology, vol.54, issue.11, pp.945-951, 2012.
DOI : 10.1111/j.1346-8138.2011.01491.x

E. Jung, B. Choi, H. Choi, B. Kim, M. Ha et al., Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Ethambutol and Rifampin, Infection & Chemotherapy, vol.44, issue.3, p.197, 2012.
DOI : 10.3947/ic.2012.44.3.197

URL : http://doi.org/10.3947/ic.2012.44.3.197

J. Cheng, S. Rawal, A. Roberts, and O. Guttman, Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Antituberculosis Medications, The Pediatric Infectious Disease Journal, vol.32, issue.12, pp.1388-90, 2013.
DOI : 10.1097/INF.0b013e3182a09f20

N. Draz, S. Datta, D. Webster, and I. Cropley, Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7). Case Rep, pp.2013010348-2013010348, 2013.
DOI : 10.1136/bcr-2013-010348

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736620

J. Kim, K. Sohn, W. Song, and H. Kang, A Case of Drug Reaction with Eosinophilia and Systemic Symptoms Induced by Ethambutol with Early Features Resembling Stevens-Johnson Syndrome, Acta Dermato Venereologica, vol.93, issue.6, pp.753-757, 2013.
DOI : 10.2340/00015555-1600

D. Kaswala, Drug rash with eosinophilia and systemic symptoms syndrome due to anti-TB medication, Journal of Family Medicine and Primary Care, vol.2, issue.1, p.83, 2013.
DOI : 10.4103/2249-4863.109958

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894017

R. Bopaka, E. Khattabi, W. Afif, H. Aichane, A. Bouayad et al., Le ????DRESS???? syndrome aux antituberculeux, Revue de Pneumologie Clinique, vol.70, issue.3, pp.185-193, 2014.
DOI : 10.1016/j.pneumo.2013.10.004

M. Kaloga, A. Diabaté, H. Kourouma, A. Sangaré, E. Ecra et al., Un cas de DRESS syndrome li?? aux antituberculeux, Annales de Dermatologie et de V??n??r??ologie, vol.141, issue.12, p.506, 2014.
DOI : 10.1016/j.annder.2014.09.194

I. Khouaja, E. Guermazi, D. Béjar, H. Kwas, and H. Ghedira, DRESS syndrome aux antituberculeux, Revue Fran??aise d'Allergologie, vol.55, issue.3, p.245
DOI : 10.1016/j.reval.2015.02.103

S. Zhang, Q. He, N. Yang, S. Ni, and M. Lu, Isoniazid-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Presenting as Acute Eosinophilic Myocarditis, Internal Medicine, vol.54, issue.10, pp.1227-1257, 2015.
DOI : 10.2169/internalmedicine.54.3511

D. Palmero, J. Castagnino, R. Musella, C. Mosca, G. Montaner et al., Difficult clinical management of anti-tuberculosis DRESS syndrome [Case study], The International Journal of Tuberculosis and Lung Disease, vol.17, issue.1, pp.76-84, 2013.
DOI : 10.5588/ijtld.12.0441

G. Lyamani, Dress syndrome under antituberculosis drugs. Fundamental and Clinical Pharmacology, 2015, vol.29, issue.52, p.52

V. Descamps, Drug reaction with eosinophilia and systemic symptoms (DRESS)]. Rev Prat, pp.1347-52, 2012.

S. Kim, S. Lee, S. Kim, H. Park, Y. Chang et al., Antituberculosis drug-induced hypersensitivity syndrome and its association with human leukocyte antigen, Tuberculosis, vol.93, issue.2, pp.270-274, 2013.
DOI : 10.1016/j.tube.2012.10.010

S. Kardaun, P. Sekula, L. Valeyrie-allanore, Y. Liss, C. Chu et al., Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study, British Journal of Dermatology, vol.333, issue.5, pp.1071-80, 2013.
DOI : 10.1111/bjd.12501

F. Skowron, B. Bensaid, B. Balme, L. Depaepe, J. Kanitakis et al., Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases, Journal of the European Academy of Dermatology and Venereology, vol.147, issue.11, 2015.
DOI : 10.1111/jdv.13212

A. Barbaud, E. Collet, B. Milpied, H. Assier, D. Staumont et al., A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions, British Journal of Dermatology, vol.33, issue.3, pp.555-62, 2013.
DOI : 10.1111/bjd.12125

R. Takahashi, Y. Kano, Y. Yamazaki, M. Kimishima, Y. Mizukawa et al., Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome, The Journal of Immunology, vol.182, issue.12, pp.8071-8080, 2009.
DOI : 10.4049/jimmunol.0804002